NEWS zu "SHMN" sohm die geht durch die decke
Seite 1 von 3 Neuester Beitrag: 29.10.10 16:07 | ||||
| Eröffnet am: | 28.10.10 15:42 | von: mark913 | Anzahl Beiträge: | 54 |
| Neuester Beitrag: | 29.10.10 16:07 | von: mark913 | Leser gesamt: | 1.228 |
| Forum: | Hot-Stocks | Leser heute: | 4 | |
| Bewertet mit: |  | |||
| Seite: < 1 | 2 | 3 > | ||||
Intraday Stock Chart
Today : Thursday 28 October 2010
SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, today announced that the Company is expanding its generic drug distribution within the emerging pharmaceutical markets in Mexico and Latin America. The Company is currently working with large scale distribution organizations to form a strategic alliance in Mexico which is expected to accelerate market penetration and revenue growth both in Mexico and Latin America. The Company's direct manufacturing of generic pharmaceuticals allows pricing advantages and distribution of quality drugs to consumers remaining underserved or with limited access to medicine in this region.
Geographically, the Latin America pharmaceutical market is vast, comprising of the eight major economies of the South American continent. Brazil is a leading market in this geography, followed by Mexico, Argentina, Venezuela, Colombia, Chile, Peru and Cuba. The pharmaceutical market in Latin America is pegged at about $50 billion with generic companies contributing almost 35 percent. As per IMS' Global Market Trends this market has a healthy growth of around 11.6 percent. With an average growth rate of 13 percent it is estimated to be worth $80 billion by 2013.
Vice President for Corporate Strategy at SOHM, Inc., Shailesh Shah, stated, "Latin America is a focus point for generic drug distribution and with $50 billion in pharmaceutical drug revenue we see a very lucrative market opportunity. Governments of these countries are offering support to further improve healthcare programs and reduce drug costs and this presents immense business opportunities to Indian drug manufacturers like SOHM. Over the next five years, the Brazilian and Mexican markets are expected to double, and we expect to be right in the middle of this growth opportunity providing cost effective generic pharmaceuticals to the population in this region."
About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com
Safe Harbor Statement
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700
SOHM (OTC) (USOTC:SHMN)
Intraday Stock Chart
Today : Thursday 28 October 2010
SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories today announced the addition of 6 new generic pharmaceutical products targeting asthma and respiratory disease. India's respiratory drug market size is approximately $600 million annually. Acute respiratory diseases in India have grown by 33 percent from 2005-2010 which is a significantly higher growth rate compared to other communicable diseases.
Respiratory diseases are one of the most common forms of ill-health plaguing the Indian population today. They are also a leading cause of hospitalization and death. Allergic respiratory disorders, in particular asthma, have recorded abnormally high levels in India. Even though genetic predisposition is one of the main factors of respiratory disease there is an increased prevalence due to urbanization, air pollution and environmental tobacco smoke.
"The market for respiratory products in India is huge," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "This market, combined with India being the TB capital of the world, makes the market potential of the additional new generic pharmaceutical products substantial. With total drug spending on respiratory disease in India at approximately $600 million we feel confident this product line will increase revenue as distribution begins this quarter."
About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com
Safe Harbor Statement
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Date : 10/29/2010 @ 8:55AM
Source : MarketWire
Stock : SOHM, Inc. (SHMN)
Quote : 0.06 0.0 (0.00%) @ 8:57AM
SOHM India to Partner With Global Efficiency Firm to Manage Triple Digit Growth Within India, Sri Lanka, Southeast Asia, Africa,
SOHM (OTC) (USOTC:SHMN)
Intraday Stock Chart
Today : Friday 29 October 2010
SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that the Company is negotiating to partner with a global efficiency firm headquartered in India. The firm will assist with managing soaring growth in India, Sri Lanka, Southeast Asia, Africa, Mexico and Latin America. Areas of concentration include the ideal route and strategies to manage triple digit growth, enhancing product offerings, improving management competencies, and effective management of the global sales force. The firm will also advise on strategic acquisitions which include additional manufacturing facilities and regional opportunities to acquire market share in key pharmaceutical markets.
"Operational enhancements, streamlining manufacturing facilities, and efficiency focused changes are exciting, and all point to the success that we are experiencing as a company," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "SOHM is growing quickly, and we are planning future growth by investing in expertise that is both aggressive and strategic. We believe hiring specialists will improve all aspects of our Company thereby increasing the efficiency and effectiveness of our operations and potentially reducing costs and improving profit margins."
About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com
Safe Harbor Statement
This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
For more information, please contact:
SOHM, Inc.
Investor Relations
(714) 522-6700